Mihail Krepchev

  • 99 Bishopsgate
  • London EC2M 3XF
  • United Kingdom

Mihail Krepchev is an associate in the London office of Latham & Watkins. Mr. Krepchev advises on technology transactions, commercial matters, data protection, intellectual property, licensing and collaboration projects, corporate acquisitions and divestments, and separations and transitional agreements.

Mr. Krepchev has particular experience representing healthcare and life sciences companies and industry investors, and regularly advises clinical trial sponsors on compliance with European data protection laws.

Mr. Krepchev’s expertise covers:

  • Technology transactions
  • Healthcare and life sciences regulation
  • Intellectual property
  • Information law, data protection, and cybersecurity
  • Commercial contracts
  • Licensing and collaborations

Mr. Krepchev’s representative matters include advising:

  • GlaxoSmithKline on the divestment of a portfolio of assets relating to seven medical device and pharmaceutical brands to Foundation Consumer Healthcare
  • Boston Scientific Corporation on its acquisition of the surgical unit of medical device firm Lumenis Ltd. for US$1.07 billion in cash upfront
  • Amphenol Corporation on its US$1.7 billion acquisition of MTS Systems
  • Cerner Corporation on its acquisition of Kantar Health, a division of Kantar Group, for US$375 million in cash
  • Atnahs Pharma on the acquisition of the global commercial rights to a portfolio of hypertension medicines from AstraZeneca
  • Acino Pharma in relation to its purchase of a portfolio of over-the-counter and prescription pharmaceutical products in the Near East, Middle East, and Africa
  • LivaNova PLC on the sale of its Cardiac Rhythm Management business franchise to MicroPort Scientific Corporation, including advising on a complex bi-lateral transitional services structure
  • Theramex on all pre-closing commercial, licensing, supply, quality, safety, separation, and transitional matters in connection with its acquisition of certain women’s health products from Teva Pharmaceutical Industries
  • A multinational pharmaceutical and medical devices company on a number of European data protection matters
  • Clinical trial sponsors on data protection compliance in the context of a number of cross-border clinical trials of investigational pharmaceutical products
  • A health technology company on the negotiation of a collaboration and intellectual property licence from a leading academic medical center
  • An American healthcare company on the data privacy aspects of an agreement with a cloud services provider for the procurement of certain software-as-a-service (SaaS) solutions
  • A UK-headquartered travel company on the reorganization of its airline tour operators
  • A major UK pension scheme on its compliance with the General Data Protection Regulation (GDPR)
  • An early-stage cleantech company on a strategic partnership agreement with a multinational utilities provider

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.